lobbying_activities: 478047

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
478047	79d5bc55-577c-4bac-bca8-627a9ecf61ee	YY	PODESTA GROUP, INC.	31680	NOVO NORDISK INC	2006	year_end	PHA	Drug safety and importation issues, Clinical trials. Generics Biologics HR 328, Pharmaceuticals Market Access Act of 2005. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing. S 3807, Enhancing Drug Safety and Innovation Act of 2006. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. S 109, Pharmaceutical Market Access Act of 2005. S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 930, Food and Drug Administration Safety Act of 2005.	Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE	100000		0	0	2007-02-12T14:50:38-05:00